OcureX Bio Technologies
OcureX Bio Technologies develops methods to prevent hair loss in patients. They combine biotech and bioinformatics using synthetic biology, nanotechnology, synthetic data AI, and next-generation sequencing to understand and halt hair-loss pathways. The company operates as a biotech and bioinformatics firm targeting hair-loss from chemotherapy, pattern baldness, and alopecia. Core technology includes synthetic biology platforms, nanotech approaches, AI-driven data analysis, and sequencing pipelines for research and potential therapies. The aim is to enable partnerships with pharma and research institutions to scale solutions across clinical development.
OcureX Bio Technologies
OcureX Bio Technologies develops methods to prevent hair loss in patients. They combine biotech and bioinformatics using synthetic biology, nanotechnology, synthetic data AI, and next-generation sequencing to understand and halt hair-loss pathways. The company operates as a biotech and bioinformatics firm targeting hair-loss from chemotherapy, pattern baldness, and alopecia. Core technology includes synthetic biology platforms, nanotech approaches, AI-driven data analysis, and sequencing pipelines for research and potential therapies. The aim is to enable partnerships with pharma and research institutions to scale solutions across clinical development.
TL;DR
Company: OcureX Bio Technologies
Focus: Preventing and treating hair loss (chemo-induced, pattern baldness, alopecia)
Tech: Synthetic biology, nanotechnology, synthetic data AI, next-generation sequencing
Founded: 2023
Headquarters: Reston, Virginia, United States
Company Overview
Problem Domain
Hair-loss prevention and treatment (chemotherapy-induced hair loss, pattern baldness, alopecia)
Founded
2023
Industry
Biotechnology
Tech Stack
Funding Track Record
Stage: Pre-Seed